|
|
 |
|
|
SCIENCE NEWS
Researchers Uncover Biological Rationale for Why Intensive Lupus Treatment Works
Researchers show in blood cells that giving very high doses of intravenous corticosteroids early and frequently in the course of the disease is more effective at killing the cells that drive lupus than giving the standard limited intravenous steroids followed by high doses of oral corticosteroids over a period of months. [Press release from the University of Texas Southwestern Medical Center discussing online prepublication in Nature]
Toxic Trio Identified as the Basis of Celiac Disease
Scientists have identified the three protein fragments that make gluten toxic to people with celiac disease. [Press release from the Walter and Eliza Hall Institute of Medical Research discussing online prepublication in Science Translational Medicine]
Therapeutic HIV Vaccines Show Promise
Researchers presented the results of a handful of successful, but small, early-phase clinical trials for therapeutic vaccines -- once thought to be a dead end for tackling HIV. [Press release from Nature News discussing research presented at the XVIII International AIDS 2010 Conference]
|
|
POLICY NEWS
Obama, Clinton Pledge U.S. Support for AIDS Fight
President Barack Obama and Secretary of State Hillary Rodham Clinton have pledged the support of the United States in the global fight against AIDS. [Department of State, United States]
Senate Spending Panel Approves $1 Billion Boost for NIH
A Senate subcommittee matched President Barack Obama's request for a $1 billion increase in 2011 for the National Institutes of Health (NIH). That raise would bring the agency's total budget to $32 billion, or 3.5% above the 2010 level, according to a statement from the Senate appropriations labor, health, and human services subcommittee. [National Institutes of Health, United States]
NIH Takes on New Role in Fight Against Rare Diseases
A government program focusing on rare diseases, the Therapeutics for Rare and Neglected Diseases (TRND) program, has launched five pilot projects that are taking the National Institutes of Health in a new direction: developing drugs. TRND will work together with scientists, advocates and others to do the required research and testing on drugs before a compound can be tried in humans in a clinical trial. [National Institutes of Health, United States]
NIH Asks for Input on Closing Loophole in Conflict-of-Interest Rule
Responding to yet another flap about the influence of drug companies on biomedical research, the National Institutes of Health (NIH) has decided it needs more time to revise its rules for policing conflicts of interest so that sanctions will move with an investigator if he or she changes institutions. [National Institutes of Health, United States]
Responsibility of Applicants for Promoting Objectivity in Research for Which Public Health Service Funding Is Sought and Responsible Prospective Contractors [Docket Number NIH-2010-0001] [Department of Health and Human Services, United States]
Agency Information Collection Activities: Proposed Collection; Comment Request [Agency for Healthcare Research and Quality, United States]
National Human Genome Research Institute; Notice of Closed Meeting (Doc. 2010-18627) [National Institutes of Health, United States]
Office of the Director; Notice of Closed Meeting (Doc. 2010-18496) [National Institutes of Health, United States]
National Institute of General Medical Sciences; Notice of Closed Meeting (Doc. 2010-18088) [National Institutes of Health, United States]
Center for Scientific Review; Notice of Closed Meeting (Doc. 2010-18052) [National Institutes of Health, United States]
Bioengineering Research Partnerships (BRP)[R01] (PAR-10-234) [National Institutes of Health, United States]
|
|
EVENTS (Listed by Date)
CHI's 5th Annual Immunotherapeutics and Vaccine Summit (ImVacS)
August 17-19, 2010
Cambridge, United States
14th International Congress of Immunology
August 22-27, 2010
Kobe, Japan
Select Biosciences 3rd Annual Stem Cells Europe Conference
August 24-25, 2010
Edinburgh, Scotland
Select Biosciences Inaugural Cellular Therapy Summit
August 24-25, 2010
Edinburgh, Scotland
Select Biosciences 7th Annual RNAi & miRNA Europe
September 14-15, 2010
Dublin, Ireland
Immunology & Microbiology, Genetics & Genomics, Development, Other
September 18-22, 2010
Barcelona, Spain
Cell Symposia: Inflammation and Disease
September 26-28, 2010
Lisbon, Portugal
11th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology - DC2010: Forum on Vaccine Science
September 26-30, 2010
Lugano, Switzerland
5th International Conference on Gene Regulation in Lymphocyte Development
October 9-14, 2010
Chania, Greece
Autumn Immunology Conference 2010
November 19-22, 2010
Chicago, United States
Cell Symposia: Influenza - Translating Basic Insights
December 2-4, 2010
Washington, D.C., United States
Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES
Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.
Have we missed an important article or publication in Immune Regulation News? Click here to submit!
Comments or Suggestions? Email info@connexoncreative.com with your feedback.
|
|
|
|
|
|
|
|
|
